Rep. David J. Taylor

Maddy summaryThe Workforce Flexibility Act amends the Workforce Innovation and Opportunity Act (WIOA) by removing a specific eligibility requirement for youth programs. It eliminates the "out-of-school priority," which previously limited certain workforce services to youth not enrolled in school. This change directly affects youth programs under WIOA, allowing them to serve a broader group of young people without that prior restriction. The bill makes a technical adjustment to program eligibility rules, not a major policy shift.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryHR 5563, the DRIVE-SAFE Act, creates a structured apprenticeship program for commercial drivers under age 21. It requires employers to provide a two-phase training program: a 120-hour probationary period focused on basic driving skills (like traffic navigation and safety awareness), followed by a 280-hour period covering advanced tasks (such as pre-trip inspections and load management). During both phases, apprentices must operate vehicles equipped with automatic transmissions, collision mitigation systems, and video capture, and must be accompanied by an experienced driver (26+ years old with no recent accidents or violations). The bill does not change existing commercial driver’s license requirements and mandates employers to maintain records and provide remediation for preventable accidents or violations during training.

Maddy summaryThis bill requires commercial motor vehicle drivers to demonstrate English proficiency to pass knowledge tests or receive certification. Starting two years after enactment, drivers must understand English traffic signs, communicate with safety officers (like border patrol), and exchange directions in English while operating vehicles. It bans administering these tests in any language other than English and mandates the Transportation Secretary to update related regulations within two years. The law directly affects commercial drivers seeking certification or renewing licenses under federal rules.

Maddy summaryThis bill is a commemorative resolution (not a law) recommending the U.S. Navy name a vessel after Rear Admiral Alene Duerk. It directs the Secretary of the Navy to honor her by naming a ship "U.S.S. Rear Admiral Alene Duerk," recognizing her service as the first woman promoted to rear admiral in the Navy. The bill details her WWII nursing service, postwar career progression, and military medals, but does not create new policy or funding. It is a non-binding expression of congressional sentiment regarding naval vessel naming.

Maddy summaryHR 6019 repeals a requirement that Senate offices must be notified when legal requests seek Senate data. Specifically, it removes Section 213 of the 2026 appropriations act, which mandated that Senate offices be informed about legal processes requesting disclosure of Senate data. This change directly affects Senate offices by eliminating a procedural notification step for legal requests involving their data. The bill makes no other policy changes, solely removing this specific administrative requirement.

Maddy summaryThis resolution (HRES 869) commemorates the 50th anniversary of the November 10, 1975, sinking of the Great Lakes freighter S.S. Edmund Fitzgerald, which resulted in the loss of all 29 crew members. It honors the memory of the 29 crew members who died in the tragedy and recognizes the enduring contributions of Great Lakes shipping to the U.S. economy and cultural heritage. The resolution also acknowledges efforts by historians, museums, and communities to preserve the ship's legacy and promote maritime education. As a commemorative resolution, it has no binding policy impact and serves solely to mark this historical event.

Maddy summaryThis bill ensures that critical firearm-related government operations continue during federal shutdowns. It designates background checks (via the FBI's National Instant Criminal Background Check System), Bureau of Alcohol, Tobacco, Firearms and Explosives enforcement, and firearm export licensing (handled by Commerce and State Departments) as essential services that must remain operational. These functions would be treated as "excepted" under federal law, meaning their employees would continue working even if other government services halt. The bill affects how background checks and firearm export licenses are processed during shutdowns but does not change gun ownership laws or eligibility.

Maddy summaryHR 5791, the BLOOD Centers Act, creates a 30-day expedited approval process for blood centers seeking to add apheresis collection devices to existing biologics licenses. It directly affects blood centers operating under FDA biologics licenses that already manage multiple locations or hold accredited status. The bill requires the FDA to approve such applications within 30 days unless safety concerns exist at the specific location or the center has systemic safety failures elsewhere. This streamlines the process for expanding blood collection capabilities without compromising safety standards.

Maddy summaryThis bill would require all states to recognize valid concealed carry permits issued by other states, allowing permit holders to carry concealed handguns (excluding machine guns) in any state that either issues such permits or doesn't prohibit concealed carry. It directly affects law-abiding gun owners with valid permits from their home state, ensuring they can carry in states with similar permit systems or no prohibitions. Key provisions include treating valid permit documents as proof of legal carry (reducing officer stops), shifting the burden of proof to prosecutors if challenged, and allowing civil lawsuits for violations with attorney's fee awards. The bill does not override state laws restricting firearms on private property or government land, nor does it affect federal gun restrictions like those in section 922(q).